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Abstract
Background: Whereas sudden death, most often associated with cardiovascular collapse, occurs in abusers of the
psychostimulant methamphetamine (METH), the underlying mechanism is much less understood. The demonstration that
successful resuscitation of an arrested heart depends on maintained functionality of the rostral ventrolateral medulla
(RVLM), which is responsible for the maintenance of stable blood pressure, suggests that failure of brain stem cardiovascular
regulation, rather than the heart, holds the key to cardiovascular collapse. We tested the hypothesis that cessation of brain
stem cardiovascular regulation because of a loss of functionality in RVLM mediated by bioenergetics failure and oxidative
stress underlies the cardiovascular collapse elicited by lethal doses of METH.
Methodology/Principal Findings: Survival rate, cardiovascular responses and biochemical or morphological changes in
RVLM induced by intravenous administration of METH in Sprague-Dawley rats were investigated. High doses of METH
induced significant mortality within 20 min that paralleled concomitant the collapse of arterial pressure or heart rate and
loss of functionality in RVLM. There were concurrent increases in the concentration of METH in serum and ventrolateral
medulla, along with tissue anoxia, cessation of microvascular perfusion and necrotic cell death in RVLM. Furthermore,
mitochondrial respiratory chain enzyme activity or electron transport capacity and ATP production in RVLM were reduced,
and mitochondria-derived superoxide anion level was augmented. All those detrimental physiological and biochemical
events were reversed on microinjection into RVLM of a mobile electron carrier in the mitochondrial respiratory chain,
coenzyme Q10; a mitochondria-targeted antioxidant and superoxide anion scavenger, Mito-TEMPO; or an oxidative stress-
induced necrotic cell death inhibitor, IM-54.
Conclusion: We conclude that sustained anoxia and cessation of local blood flow that leads to bioenergetics failure and
oxidative stress because of mitochondrial dysfunction, leading to acute necrotic cell death in RVLM underpins
cardiovascular collapse elicited by lethal doses of METH.
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Introduction
The psychostimulant methamphetamine (N-methyl-1-phenyl-
propan-2-amine; METH) is a cationic lipophilic molecule with
potent actions on the central and sympathetic nervous system, and
affects neurochemical mechanisms responsible for regulating
attention, mood and emotional responses associated with alertness
or alarm conditions, body temperature, blood pressure, heart rate
and appetite [1]. Because it heightens alertness and energy,
induces euphoria, enhances self-respect and increases sexual
pleasure, METH possesses high potential for abuse and addiction
and has become a serious societal problem worldwide [2,3]. At
issue is that METH abusers have to constantly increase dosing to
sustain an elevated mood and libido and a decrease in appetite and
fatigue. As such, METH intoxication is a common cause of death
within the abuse population [4,5]. Worse still, continuous use at
larger doses results in not only acute METH poisoning but also
METH-induced sudden death [6–8].
Death from METH abuse has been associated with cardiovas-
cular collapse, cerebral edema and diffuse petechial hemorrhage in
brain [6,9]. In particular, severe hypotension and bradycardia are
critical omens in patients who exhibit acute METH intoxication
[7,9]. Because of the irreversible cardiovascular failure that rapidly
leads to death, treatment for METH intoxication is generally
difficult [8], with 100% mortality despite intensive care in a
hospital setting [9]. The prevalence of METH-induced cardiovas-
cular collapse that leads to death notwithstanding, the underlying
mechanism is much less understood.
Three important clues on delineating the mechanisms that may
underlie METH-induced cardiovascular collapse arise from
studies by our laboratory and others on brain death. The first
clue comes from the prognosis that asystole invariably takes place,
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permanent impairment of the brain stem cardiovascular regulatory
machinery should precede the inevitable death [11]. Another
crucial clue arises from the identification by our laboratory of a
common prognostic determinant among comatose patients [11]
who succumbed to systemic inflammatory response syndrome,
severe brain injury or organophosphate poisoning. A dramatic
reduction or loss of the power density of the low-frequency (LF)
component (0.04–0.15 Hz in human) in the power spectrum of
arterial pressure signals consistently takes place before significant
hypotension and the eventual asystole occur. We also demonstrated
[12] that the origin of this life-and-death signal resides in the rostral
ventrolateral medulla (RVLM), which is long known to be
responsible for the maintenance of sympathetic vasomotor tone
and stable blood pressure [13]. The third clue comes from our
demonstration that successful resuscitation of an arrested heart
dependsonmaintained functionalityofRVLM[14],suggesting that
failure of brain stem cardiovascular regulation, rather than the
heart, holds the key to cardiovascular collapse.
Cerebrovascular pathology, most commonly hypoxia and
hemorrhage, is present in 20% of cases in METH-elicited death
[4,15]. Of particular interests is that our laboratory found
previously in experimental brain death models that the degree of
tissue hypoxia in RVLM is a crucial determinant of the severity of
central circulatory regulatory dysfunction [14,16]. An immediate
corollary that arises, which forms the hypothesis for the present
study, is that cessation of brain stem cardiovascular regulation that
resembles that in brain death because of the loss of functionality in
RVLM may underlie the cardiovascular collapse elicited by
METH. This hypothesis was validated in the present study. We
further demonstrated that sustained anoxia and cessation of local
blood flow, followed by acute bioenergetic failure because of
mitochondrial dysfunction that leads to necrotic cell death in
RVLM underlie METH-induced shutdown of central cardiovas-
cular regulation that precedes cardiovascular collapse.
Results
Lethal doses of METH induce cardiovascular collapse
Intravenous administration of METH (24, 48 or 60 mg/kg)
elicited a dose-dependent decrease in survival rate (Figure 1A). At
a dose of 24 mg/kg, METH was effective in reducing the survival
rate by 60% within 20 min; increasing the doses to 48 or 60 mg/
kg further exacerbated the mortality rate to 90% or 100% by
20 min. In rats that died, there was a dose-dependent collapse of
arterial pressure (Figure 1B) and heart rate (Figure 1C) that
paralleled the time-course of mortality, with a progressive
reduction in response latency. The LF component of the systolic
blood pressure (SBP) spectrum underwent a transient increase that
exhibited a dose-dependent reduction in peak power and response
latency (Figure 1D), followed by the disappearance of this life-and-
death signal that also paralleled temporally with mortality.
However, survival rate (Figure 1A) or cardiovascular responses
(Figure 1B–D) were not affected by intravenous administration of
saline (vehicle control).
Anoxia and cessation of tissue perfusion in RVLM
Our laboratory demonstrated previously [14] that anoxia and
zero tissue perfusion in RVLM precede sustained cessation of LF
power and cardiovascular collapse seen during experimental brain
death. Figure 2 shows that in rats that succumbed to METH (24 or
48 mg/kg, i.v.), there was also an abrupt anoxia and cessation of
local microvascular perfusion in RVLM. Of note was that those
events exhibited a latency that was shorter than the cardiovascular
responses induced by the same doses of METH. On the other
hand, administration of saline induced insignificant changes in
tissue oxygen level and local blood flow in RVLM. On the other
hand, simultaneous measurement of in situ temperature revealed
insignificant differences in RVLM tissue temperature between
saline-control group (34.560.2uC), rats that survived after METH
at 24 mg/kg (34.860.3uC) and rats that died of METH at 24
(33.860.5uC) or 48 mg/kg (33.760.3uC).
RVLM as a site of action for intravenously administered
METH
A crucial prerequisite for RVLM to be a site of action for
METH is for the psychostimulant to reach this neural substrate on
systemic administration. In addition to a dose-dependent increase
of METH in serum (Figure 3A), we detected the same trend in
tissue samples (Figure 3B) and extracellular fluid (Figure 3C)
collected from RVLM in rats that died of intravenous adminis-
tration of METH (24 or 48 mg/kg). Double immunofluorescence
staining coupled with laser scanning confocal microscopy further
showed that in addition to a clearly defined nucleus and nucleolus
in cells stained positively with the neuronal marker, neuron-
specific nuclear protein (NeuN) (Figures 3D,E), METH-immuno-
reactivity was present in the cytoplasm and nucleus of RVLM
neurons (Figure 3E) from animals that died of METH.
Necrotic cell death in RVLM
Hematoxylin and eosin (H&E) staining revealed that present in
RVLM of rats that died of METH (48 mg/kg, i.v.) were necrosis-
appearing cells (Figure 4) characterized by shrinkage of cytoplasm,
chromatolysis (disruption of Nissl bodies), karyolysis (nuclear
fading) and karyorrhexis (nuclear fragmentation). On the other
hand, 81.961.1% of cells in RVLM of saline-control rats
exhibited clearly hematoxylin-labeled nucleolus, intact nuclear
membrane, nucleus and cytoplasm were observed (Figure 4), as
opposed to 13.861.9% in the METH (48 mg/kg, i.v.) group.
Likewise, the ratio of RVLM cells that manifested chromatolysis
(23.761.2% versus 3.760.7%), karyolysis (40.662.5% versus
7.661.1%) and karyorrehexis (21.961.4% versus 6.860.5%) in
the METH group was higher than those in the saline-control
group. In contrast, activated caspase-3 and histone-associated
DNA fragments, two hallmark experimental indices for apoptosis,
were absent from RVLM of rats that received saline or died of
METH (Figure 5).
Bioenergetic failure that leads to necrotic cell death
because of mitochondrial dysfunction in RVLM
Because ATP is the primary source of metabolic energy in
neurons, neurons tend to undergo necrosis in response to anoxic
stress [17]. We found that animals died of METH (24 mg/kg, i.v.)
exhibited a drastic reduction in ATP production and an increase
in ADP level or ADP/ATP ratio in RVLM (Figure 6A), alongside
elevated PI uptake indicative of necrotic cell death (Figure 6B). In
addition to maintaining survival, all those four responses were
reversed by microinjection bilaterally of Mito-TEMPO (500 pmol)
or CoQ10 (7 nmol) into RVLM (Figures 6A,B); and IM-54 (3
pmol) blunted the elevated PI level (Figure 6B). We further
observed a depression of the activities of Complexes I, II, III and
V (Figures 6A–C,E), NADH cytochrome c reductase (NCCR) or
succinate cytochrome c reductase (SCCR) (Figures 7F,G), but not
Complex IV (Figure 6D), in the mitochondrial respiratory chain in
RVLM of rats that succumbed to METH (24 mg/kg, i.v.). Again,
those depressive actions were antagonized by CoQ10 (7 nmol) or
Mito-TEMPO (500 pmol) (Figures 7A–C,E–G).
Cardiovascular Collapse/Methamphetamine Fatality
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In rats that died of METH (24 mg/kg, i.v.), there was also an
increase of mitochondria-derived superoxide anion level in RVLM
as demonstrated by enzyme-linked immunosorbent assay (ELISA)
(Figure 8A) or represented by the intensity of fluorescence from a
mitochondrial superoxide indicator (Tyagi et al., 2010), MitoSOX
(Figure 8B). Microinjection bilaterally of CoQ10 (7 nmol) or Mito-
TEMPO (500 pmol) again significantly blunted those responses
(Figures 8A,B). On the other hand, negligible superoxide anion
was observed in RVLM (Figures 8A,B) of sham-controls or saline-
treated rats.
Mitochondrial dysfunction, bioenergetic failure, oxidative
stress and necrotic cell death in RVLM underlie METH-
induced cardiovascular collapse and mortality
Microinjection of CoQ10, Mito-TEMPO or IM-54 bilaterally
into RVLM, at a dose that antagonized mitochondrial dysfunc-
tion, bioenergetic failure, oxidative stress or necrotic cell death in
RVLM (Figure 9), significantly sustained survival (vehicle+METH,
40%; CoQ10+METH, 78%; Mito-TEMPO+METH, 70%; IM-
54+METH, 85%) by antagonizing arterial pressure collapse,
asystole and disappearance of power density of the LF spectral
component induced by intravenous administration of a lethal dose
of METH (24 mg/kg).
Discussion
A majority of the investigations on METH focuses on the
behavioral alterations, physical dependence or psychopathology of
withdrawal syndrome and its management that are associated with
this psychostimulant. Much less studies are devoted to the
mechanisms of METH intoxication despite that it is a common
cause of death within the abuse population [4,5]. Based on a fatal
METH intoxication model, the present study provided the first
demonstration that acute cessation of brain stem cardiovascular
Figure 1. Methamphetamine dose-dependently and time-dependently elicited mortality and cardiovascular collapse. Temporal
changes in survival rate (A), mean arterial pressure (MAP; B), heart rate (HR; C) or power density of the low-frequency (LF) component of systolic blood
pressure signals (D) in rats that received (at arrow) intravenous (i.v.) METH or saline (vehicle control). Values are mean 6 SEM, n=5–62 animals per
experimental group. *P,0.05 versus saline group in the Fisher Exact Test (A), or at corresponding time-points in the post hoc Scheffe ´ multiple-range
test (C–D). B, baseline.
doi:10.1371/journal.pone.0030589.g001
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cell death in RVLM underpins METH-induced cardiovascular
collapse. We further demonstrated that the repertoire of
interposing cellular events triggered by METH in RVLM includes
sustained anoxia and zero tissue perfusion that leads to
bioenergetics failure and oxidative stress because of mitochondrial
dysfunction (Figure 10).
The experimental design of the present study addresses
specifically the mechanisms of METH-induced cardiovascular
collapse rather than to model consequences of human METH
abuse. As such, we chose intravenous administration of METH in
our study because this is a common route [18] that is employed by
abusers to rapidly raise the blood concentration of METH to
euphoric levels. At the same time, we chose to employ high doses
of METH that would result in cardiovascular collapse and fatality
to mimic observations from clinical conditions [19,20]. Compared
to its primary metabolite amphetamine, METH is more lipid-
soluble, with enhanced transport across the blood-brain barrier
and stability against enzymatic degradation by monoamine
oxidase [21]. Indeed, our pharmacokinetic data indicated that
10 min after intravenous administration, the concentration of
METH in the extracellular microenvironment of RVLM was
already 10 times higher than that in serum, approaching a plateau
within 20 min. With the high tissue concentration detected in
ventrolateral medulla and the demonstrated presence of METH in
RVLM neurons, the present study established RVLM as a
relatively unknown though vital brain targets for this psychostim-
ulant.
The present results were highly reminiscent of those in a recent
study from our laboratory [14] that showed that a crucial
determinant for successful revival of an arrested heart is that
spontaneous circulation must resume before brain death com-
mences, and that maintained functional integrity of RVLM holds
the key to this vital time-window. Our results showed that a time-
window represented experimentally by the power density of the LF
component of the SBP spectrum also exists between the
administration of METH and death, and was inversely related
to the doses used. We further demonstrated that sustained anoxia,
which took place as early as 2 min after intravenous administra-
tion of METH at 48 mg/kg, followed 4–6 min later by cessation
of tissue perfusion, accounts for the loss of functionality of RVLM.
Of note is that this time-window parallels the time taken for
extracellular concentration of METH in RVLM to reach plateau.
Given that RVLM is long known to be responsible for the
maintenance of sympathetic vasomotor tone and stable blood
pressure [13], and is the origin of a life-and-death signal [12] that
disappears in patients confirmed of brain death [11], the selective
vulnerability of this neural substrate to METH-induced toxicity is
to be anticipated.
Neuronal functions are critically dependent on a continuous
supply of oxygen because their primary source of metabolic energy
is oxidative phosphorylation in the mitochondrion. The mito-
chondrial respiratory chain located in the inner membrane of
mitochondria comprises of Complexes I, II, III, IV and V (ATP
synthase). Orderly transfer of electrons through this chain
produces energy in the form of ATP. A disruption of electron
transfer not only decreases ATP production but also leaks
electrons from the inner membrane to the matrix that results in
the formation of reactive oxygen species (ROS) primarily in the
form of superoxide anions. The mitochondrion is also the primary
site of oxygen consumption in the cell, and as such is highly
susceptibility to anoxia. The drastic reduction in ATP production
and increase in ADP level or ADP/ATP ratio, alongside
significant depression of the activity of most of the mitochondrial
respiratory chain Complexes, reduction of the capacity of electron
transport between Complexes I to III (NCCR) and II to III
(SCCR), and augmentation of mitochondria-derived superoxide
anion in RVLM of rats that died of METH strongly support the
notion that bioenergetic failure and oxidative stress triggered by
anoxia and cessation of tissue perfusion precipitate the eventual
cessation of neuronal functions in RVLM. We noted that METH
induces mitochondrial damage via production of ROS in rat
hippocampal neural progenitor cells [22] and human dopaminer-
gic neuroblastoma SH-SY5Y cells [23]. Aberrant mitochondrial
Figure 2. Methamphetamine dose-dependently and time-
dependently elicited anoxia and cessation of microperfusion
in rostral ventrolateral medulla. Temporal changes in tissue partial
pressure of oxygen and blood flow detected in rostral ventrolateral
medulla (RVLM) of animals that died of intravenous administration of
METH (at arrow). Values are mean 6 SEM, n=5–9 animals per
experimental group. *P,0.05 versus saline group at corresponding
time-points in the post hoc Scheffe ´ multiple-range test. B, baseline.
doi:10.1371/journal.pone.0030589.g002
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METH-induced neurotoxic effects in SH-SY5Y cell line [24].
Depressive effects of METH on the activity of mitochondrial
respiratory chain complexes have also been reported [25]. In
spontaneously hypertensive rats, the increased superoxide anions
in RVLM can also take origin from NADPH oxidase [26].
Whether this source of ROS is involved in METH-induced
oxidative stress in RVLM requires further elucidation.
Postmortem studies showed that cerebral edema [27] or brain
stem hematoma [15] is a common clinical phenotype in patients
died of METH intoxication. The present study demonstrated that
damage to RVLM in the form of necrotic cell death is a
contributing factor to METH-induced mortality. A critical
determinant of the eventual cell death fate resides in intracellular
ATP concentration. Whereas ATP is required for the development
of apoptosis, ATP depletion is associated with necrosis [28]. Thus,
the significant depletion of intracellular ATP content induced by
lethal doses of METH, together with the characteristic morpho-
logical features under H&E stain and the uptake of PI, are
indicative of damage of cell membrane integrity, leading to
necrotic cell death in RVLM. The absence of activated caspase-3
and histone-associated DNA fragments, two hallmark experimen-
tal indices for apoptosis, in RVLM of rats that died of METH
further supports the validity of this notion. We previously found
that lethal dose of organophosphate pesticide mevinphos induced
anoxia-induced bioenergetics failure and subsequent necrotic cell
death in RVLM, resulting in cardiovascular collapse prior to
cessation of life. On the other hand, sub-lethal dose of mevinphos
elicited hypoxia-dependent and mitochondria-dependent apoptot-
ic cell death in RVLM that result in dysfunction of brain stem
cardiovascular regulation and hypotension [29–32]. It follows that,
subject to confirmation, sub-lethal doses of METH may only
induce hypoxia in RVLM, leading to apoptotic cell death that is
accompanied by brain stem cardiovascular dysfunction without
imminent death.
In addition to mitochondria, the endoplasmic reticulum is
reported recently to be another target of ROS [33]. Whereas the
contribution of endoplasmic reticulum to METH-induced necrotic
cell death in RVLM cannot be ruled out, we noted that ROS-
mediated endoplasmic reticulum stress is mainly responsible for
apoptosis induced by proapoptotic inducer in cancer cells [33,34].
Because of the similarities in cellular programming for apoptosis
and autophagy [35,36], the lack of participation of apoptotic cell
death in RVLM during METH-induced cardiovascular collapse
observed in the present study deemed the involvement of
autophagy in this process minimal.
The effectiveness of CoQ10, Mito-TEMPO or IM-54 to sustain
survival, antagonize arterial pressure collapse, asystole and
disappearance of power density of the LF spectral component,
and blunt mitochondrial dysfunction, bioenergetics failure,
oxidative stress or necrotic cell death in RVLM induced by lethal
doses of METH provided the most crucial documentation that
these events are causally related. CoQ10 is an essential component
of the mitochondrial electron transport chain [37], and the
concentration of CoQ10 in the mitochondrial membrane is related
to the rate of electron transfer and respiratory function [38]. By
enhancing quantitatively the availability of freely mobile electron
carriers and qualitatively the efficacy of electron transfer across the
mitochondrial respiratory chain [39], CoQ10 may also avail more
oxygen to the neurons for oxidative phosphorylation. Mito-
TEMPO is a recently developed mitochondria-targeted antioxi-
dant and superoxide dismutase mimetic [40] that prevents loss of
mitochondrial membrane potential or increase in mitochondrial
permeability transition pore opening and necrosis in epithelial cells
that are subject to ATP depletion [41]. Mito-TEMPO also
decreases mitochondrial superoxide level, prevents mitochondrial
oxidative damage or mitochondrial dysfunction and attenuates
hypertension elicited in mice by angiotensin II or DOCA salt [40].
IM-54 is a recently developed tool for investigating the molecular
mechanism of oxidative stress-induced necrosis. It inhibits necrotic
cell death in hydrogen peroxide-treated HL60 cells or in
anticancer agent chrysophanol-treated J5 human liver cancer cells
[42], but not in etoposide-induced apoptotic cell death [43].
We are aware that heart failure is another common phenomenon
observed in patients died of METH, and METH may act directly
on the heart on intravenous administration [6,8,9]. As such, the
possibility exists for depression of cardiac functions, rather than
failure of brain stem cardiovascular regulation, to be primarily
responsible for our observed METH-induced cardiovascular
collapse. However, our results deemed this possibility minimal.
Pretreatments with CoQ10, Mito-TEMPO or IM-54, at a dose that
antagonized mitochondrial dysfunction (Figure 7), bioenergetic
failure (Figure 6), oxidative stress (Figure 8) or necrotic cell death
(Figure 6) in RVLM, significantly antagonized the cessation in
arterial pressure or heart rate and disappearance of the LF spectral
component (Figure 9) induced by intravenous administration of a
lethal dose of METH, along with sustained survival.
Subcutaneous administration of METH (9 mg/kg) has been
reported to elicit hyperthermia and structural or functional
abnormalities in rat nucleus accumbens [44], cortex, hippocam-
pus, thalamus and hypothalamus [45]. In particular, acute brain
edema induced by the inflow of simple ions promoted by a
breakdown of blood-brain barrier presents serious consequences
[46]. Since animals that died of METH did not manifest
significant changes of tissue temperature in RVLM, we reason
that the neurotoxicity we observed in this neural substrate may not
be the result of local hyperthermia. On the other hand, it is
plausible that the cellular consequences induced by METH in the
forebrain structures may also take place in RVLM. Further
experiments are required to address this issue.
In conclusion, the present study revealed that lethal doses of
METH elicit cardiovascular collapse by inducing an acute loss of
functionality in RVLM via necrotic cell death, which leads to the
cessation of brain stem cardiovascular regulation that resembles
that in brain death. We further showed that the underlying cellular
events include mitochondrial dysfunction that leads to depletion of
ATP production (bioenergetic failure) and upregulation of
mitochondrial superoxide anion (oxidative stress) because of
sustained anoxia and zero tissue perfusion in RVLM. This
information should offer novel leads for devising clinical
Figure 3. Presence of methamphetamine in RVLM neurons after intravenous administration. (A–C). Changes in concentration of METH in
serum (A), ventrolateral medulla (B) or extracellular fluid collected from RVLM (C) of rats that died of intravenous administration of METH (at arrow).
Values are mean 6 SEM, n=4–9 animals per experimental group. *P,0.05 versus saline group at corresponding time-points in the post hoc Scheffe ´
multiple-range test. ND, not detected. (D–E). Representative laser scanning confocal microscopic images showing cells in RVLM that were
immunoreactive to METH (METH-IR; green fluorescence) and additionally stained positively for a neuronal marker, neuron-specific nuclear protein
(NeuN; red fluorescence) in rats that received saline (D) or died of METH (48 mg/kg, i.v.; E) group. These results are typical of 4 animals from each
experimental group. Scale bar, 20 mm. White arrow, METH-IR cells in RVLM; white arrowhead, RVLM neurons which were double stained with METH-IR
and NeuN.
doi:10.1371/journal.pone.0030589.g003
Cardiovascular Collapse/Methamphetamine Fatality
PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e30589management or developing therapeutic strategies against the
increasing number of sudden death from METH abusers. Since
the mechanisms that we identified for METH-induced cardiovas-
cular collapse are also shared by other pathologies, including brain
death and resuscitation of an arrested heart, our observations may
have even broader clinical ramifications.
Figure 4. Methamphetamine induced necrotic cell death in RVLM. Representative photomicrographs of tissues stained by hematoxylin and
eosin (H&E) showing nuclear pyknosis and chromatolysis in RVLM neurons of rats that received saline (A–C) or died of METH (48 mg/kg, i.v.) (D–F).
These results are typical of 4–5 animals from each experimental group. Scale bar, 5 mm. NA, nucleus ambiguus; n, nucleus; yellow arrow,
chromatolysis in RVLM neuron; white arrow, karyorrhexis in RVLM neurons; green symbol (*), karyolysis in RVLM neuron.
doi:10.1371/journal.pone.0030589.g004
Cardiovascular Collapse/Methamphetamine Fatality
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Ethics statement
All experimental procedures carried out in this study were
approved by the Institutional Animal Care and Use Committee of
the Kaohsiung Chang Gung Memorial Hospital (CGMH891071),
and were in compliance with the guidelines for animal care and
use set forth by that committee. All efforts were made to reduce
the number of animals used and to minimize animal suffering
during the experiment.
Animals
Specific pathogen-free adult, male, Sprague-Dawley rats (260 to
325 g, n=200) purchased from the Experimental Animal Center of
theNational Science Council and BioLASCO,Taiwan,Republicof
China, were used. They were housed in an Association for
Assessment and Accreditation of Laboratory Animal Care (AAA-
LAC) International-accredited animal facility under temperature
control (24–25uC) and 12-h light-dark cycle. Standard laboratory
rat chow and tap water were available ad libitum.
General preparation
Under an induction dose of pentobarbital sodium (50 mg/kg,
i.p.), rats received preparatory surgery that included tracheal
intubation and cannulation of the femoral artery and vein.
Animals received thereafter an intravenous infusion of propofol
(20–25 mg/kg/h; Zeneca, Macclesfield, England), which provided
satisfactory maintenance of anesthesia while preserving the
capacity of central cardiovascular regulation [47]. During the
recording sessions, animals were allowed to breathe spontaneously
with room air, and body temperature was maintained at 37uCb ya
heating pad.
Recording of cardiovascular parameters
Arterial pressure (AP) signals recorded from the femoral artery
were processed by an arterial blood pressure analyzer (APR31a;
Notocord, Croissy-Sur-Seine, France) and the SBP signals were
subject simultaneously to online and real-time spectral analysis
(SPA10a; Notocord). We were particularly interested in the LF
(0.25–0.8 Hz) component because it takes origin from RVLM
[12], and its power density mirrors the prevalence of baroreflex-
mediated sympathetic neurogenic vasomotor discharges that
emanate from RVLM [48] and is therefore a reasonable index
for brain stem cardiovascular regulation. With particular reference
to the present study, the increase or decrease in LF power was also
used to reflect lower or higher probability of manifesting brain
death [11,49–51]. Heart rate (HR) was derived instantaneously
from AP signals.
Intravenous administration of METH
METH was purchased from the Food and Drug Administra-
tion, Department of Health, Executive Yuan, Taipei, Taiwan. It
was administered intravenously, with saline serving as the vehicle
control. Temporal changes in pulsatile AP, mean AP (MAP), HR
and power density of the LF component were routinely followed
for 20 min in an on-line and real-time manner [14,16,52], or until
the animal succumbed to METH. The survival rate within
240 min was also recorded.
Measurement of tissue oxygen tension, microvascular
perfusion and temperature in rostral ventrolateral
medulla
Simultaneous and continuous measurement of tissue oxygen
tension, blood flow and temperature (Oxford Optronix, Oxford,
England) was carried out by a combined oxygen/temperature/
blood flow probe stereotaxically positioned into the RVLM
[14,52]. The coordinates used were: 4.5 to 5 mm posterior to
lambda, 1.8 to 2.1 mm lateral to midline and 8.1 to 8.4 mm below
dorsal surface of cerebellum. Instantaneous changes in local
oxygen tension, compensated for fluctuations in tissue tempera-
ture, were processed by an OxyLite monitor (Oxford Optronix).
Real-time microvascular red blood cell perfusion in tissue was
processed by an OxyFlo monitor (Oxford Optronix). Laser
Doppler signals from the tissue were recorded in blood perfusion
units (BPU), which is a relative unit defined against a controlled
motility standard.
Collection of tissues from RVLM
We routinely collected tissue samples [52–54] immediately after
rats died of METH or 20 min after intravenous administration of
saline in rats killed with an overdose of pentobarbital sodium.
Tissue samples from both sides of the ventrolateral medulla, at the
level of RVLM (0.5–1.5 mm rostral to the obex), were collected by
micropunches made with a 1-mm (i.d.) stainless-steel bore to cover
the anatomical boundaries of RVLM, with a diameter of 625–
650 mm [52]. In some experiments, medullary tissues collected
from anesthetized animals but without receiving experimental
manipulations served as the sham controls.
Figure 5. Methamphetamine did not induce apoptotic cell
death in RVLM. Changes of activated caspase-3 or histone-associated
DNA fragments in fold relative to sham-control group in samples
collected from RVLM of rats that received saline or died of intravenous
administration of METH. Values are mean 6 SEM, n=5–7 animals per
experimental group. P.0.05 among all groups in one-way ANOVA.
doi:10.1371/journal.pone.0030589.g005
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e30589Figure 6. Methamphetamine induced bioenergetics failure in RVLM. (A). Fold changes relative to sham-control group in the level of ATP,
ADP or ADP/ATP ratio in samples collected from RVLM of rats that died of METH (24 mg/kg, i.v.) or survived with pretreatment by microinjection of
Mito-TEMPO (500 pmol) or coenzyme Q10 (CoQ10; 7 nmol) into RVLM prior to METH administration. Values are mean 6 SEM, n=3–5 animals per
experimental group. *P,0.05 versus Vehicle+Saline group, and
#P,0.05 versus Vehicle+METH group in the post hoc Scheffe ´ multiple-range test. (B).
Representative laser scanning confocal microscopic images superimposed on phase contrast images showing neurons in RVLM that were
immunoreactive to propidium iodide in rats that received saline (B1), died of METH (24 mg/kg, i.v.; B2), or survived with pretreatment by
microinjection of CoQ10 (7 nmol; B3) or IM-54 (3 pmol; B4) into bilateral RVLM prior to METH administration. These results are typical of 4 animals
from each experimental group. Scale bar, 100 mm. NA, nucleus ambiguus.
doi:10.1371/journal.pone.0030589.g006
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PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e30589Figure 7. Methamphetamine induced mitochondrial dysfunction in RVLM. Fold changes relative to sham-control group in the activity of
Complex I (A), II (B), III (C), IV (D) or V (E) and electron transfer capacity between Complexes I and III (NCCR; F)or II and III (SCCR; G) in the mitochondrial
respiratory chain in samples collected from RVLM of rats died of METH (24 mg/kg, i.v.) or survived with pretreatment by microinjection of Mito-
TEMPO (500 pmol) or coenzyme Q10 (CoQ10; 7 nmol) into bilateral RVLM prior to METH administration. Values are mean 6 SEM, n=4–5 animals per
experimental group. *P,0.05 versus Vehicle+Saline group, and
#P,0.05 versus Vehicle+METH group in the post hoc Scheffe ´ multiple-range test.
doi:10.1371/journal.pone.0030589.g007
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or extracellular fluid from RVLM
The level of METH in serum, ventrolateral medulla or perfusate
collected from RVLM was determined by a commercial METH
indirect ELISA kit (Calbiotech, Spring Valley, CA, USA), in
conjunctionwithaspectrophotometer(MultiskanSpectrum,Thermo
Fisher Scientific Waltham, MA, USA) [55,56]. Blood (100 ml) drawn
from the femoral vein was centrifuged to obtain serum samples,
w h i c hw e r ef r o z e na t280uC until analysis. The perfusate from the
extracellular space of RVLM was continuously collected at 10-min
interval via a microdialysis probe (CMA/Microdialysis, Stockholm,
Sweden) stereotaxically positioned into RVLM and perfused with
artificial cerebrospinal fluid (aCSF) at a rate of 1 ml/min.
Immunofluorescence staining and confocal microscopy
We employed double immunofluorescence staining coupled with
laser scanning confocal microscopy [14,57,58] to detect localization
of METH in RVLM neurons using a rabbit polyclonal antiserum
against METH (Abcam, Cambridge, MA, USA), and a mouse
monoclonal antiserum against a specific neuron marker, NeuN
(Millipore, Billerica, MA, USA). The secondary antisera (Molecular
Probes, Eugene, OR, USA) used included a goat anti-rabbit IgG
conjugated with Alexa Fluor 488 for METH, and a goat anti-mouse
IgG conjugated with Alexa Fluor 568 for NeuN. Tissues similarly
processed but omitting primary antiserum against METH served as
our negative controls. Immunoreactivity was viewed under a
Fluorview FV10i laser scanning confocal microscope (Olympus,
Tokyo, Japan).
H&E staining
Brain stem fixed in 10% buffered formalin for 48 h were
embedded in paraffin wax and processed for H&E staining
[59,60]. Four mm-thick tissue sections were dewaxed in xylene,
hydrated in decreasing percentages of alcohol and stained with
hematoxylin (Merck Millipore, Darmstadt, Germany). This was
followed by dehydration in increasing percentages of alcohol until
70%, staining with 0.25% eosin (Merck Millipore) in alcohol,
differentiation in 90% alcohol, clearing in xylene and finally
coverslipped in mounting medium (Merck Millipore). The stained
sections were observed and photographed under an optical
microscope (Olympus).
Propidium iodide (PI) staining
Uptake of PI by RVLM neurons as a marker for necrotic cell
death [61,62] was determined by the exhibition of red fluorescence
under laser scanning confocal microscopy (Olympus). PI (5 pmol;
Sigma-Aldrich, Saint Louis, MO, USA) was microinjected
bilaterally into RVLM 30 min before METH or vehicle
administration.
Experimental indices for apoptosis
To quantify apoptosis, a cell death ELISA kit (Roche Applied
Science, Indianapolis, IN, USA) that detects apoptotic but not
necroticcelldeath was used to measure the level of histone-associated
DNA fragments in the cytoplasm [57], in conjunction with an ELISA
microtiter plate reader (Anthros Labtec, Salzburg, Austria). To
quantify activated caspase-3, a caspase-3 fluorescence assay kit
(Cayman, Ann Arbor, MI, USA) coupled with a spectrofluorometer
(Fluoroskan Ascent FL, Thermo Fisher Scientific Inc.) was used.
Microinjection of test agents to RVLM
Microinjection bilaterally of test agents into RVLM, each at a
volume of 50 nl, was carried out stereotaxically and sequentially
Figure 8. Methamphetamine increased production of mito-
chondrial superoxide anions in RVLM. (A). Fold changes relative to
sham-control group in mitochondrial superoxide anion in sample
collected from RVLM of rats died of METH (24 mg/kg, i.v.) or survived
with pretreatment by microinjection of Mito-TEMPO (500 pmol) or
coenzyme Q10 (CoQ10; 7 nmol) into RVLM prior to METH administra-
tion. Values are mean 6 SEM, n=3–6 animals per experimental group.
*P,0.05 versus Vehicle+Saline group, and
#P,0.05 versus Vehicle+-
METH group in the post hoc Scheffe ´ multiple-range test. (B).
Representative laser scanning confocal microscopic images superim-
posed on phase contrast images showing neurons in RVLM that were
immunoreactive to MitoSOX in rats that received saline (B1), died of
METH (24 mg/kg, i.v.; B2), or survived with pretreatment by microin-
jection of Mito-TEMPO (500 pmol; B3) or CoQ10 (7 nmol; B4) into
bilateral RVLM prior to METH administration. These results are typical of
4 animals from each experimental group. Scale bar, 100 mm.
Pseudocolor scale bar, white color represented highest and blue color
represented lightest fluorescence intensity. NA, nucleus ambiguus.
doi:10.1371/journal.pone.0030589.g008
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(Hamilton, Reno, NV, USA) [16,52,58]. Test agents used included
a mobile electron carrier in the mitochondrial respiratory chain
[37], coenzyme Q10 (CoQ10); gift kindly from PharmaEssentia,
Taipei, Taiwan); a mitochondria-targeted antioxidant and super-
oxide anion scavenger [40,41], [(2-(2,2,6,6-tetramethylpiperidin-1-
oxyl-4-ylamino)-2- oxoethyl)triphenylphosphonium chloride]
(Mito-TEMPO; Enzo Life Sciences, Plymouth Meeting, PA,
USA); an oxidative stress-induced necrotic cell death inhibitor
[43,63], 2-[1H-indol-3-yl]-3-pentylamino-maleimide (IM-54;
Santa Cruz Biotechnology, Santa Cruz, CA, USA); a highly
selective fluorogenic indicator for mitochondrial superoxide [64],
Figure 9. Oxidative stress in RVLM underlied methamphetamine-elicited cardiovascular collapse. Temporal changes in MAP, HR or
power density of the LF component of systolic blood pressure signals in rats that received saline, died of METH (24 mg/kg, i.v.) or survived with
pretreatment by microinjection of CoQ10 (7 nmol), Mito-TEMPO (500 pmol) or IM-54 (3 pmol) into bilateral RVLM prior to METH administration.
Values are mean 6 SEM, n=6–37 animals per experimental group. *P,0.05 versus Vehicle+Saline group, and
+P,0.05 versus Vehicle+METH group in
the post hoc Scheffe ´ multiple-range test.
doi:10.1371/journal.pone.0030589.g009
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Molecular probes) or PI (Sigma-Aldrich), with distilled water
(solvent for CoQ10 and Mito-TEMPO) or 0.2% DMSO (solvent
for IM-54 and MitoSOX) serving as the vehicle control. To avoid
the confounding effects of drug interactions, each animal received
only one freshly prepared pharmacological pretreatment.
Measurement of ATP or ADP concentration
An ApoSENSOR ADP/ATP ratio assay (BioVision, Mountain
View, CA, USA) was used to determine ATP or ADP
concentration and ADP/ATP ratio [65]. Light emitted from a
luciferase mediated reaction and measured by a luminometer
(Berthold Detection Systems GmbH, Pforzheim, Germany) was
used to calculate the measured values.
Assay for mitochondrial electron transport chain complex
enzyme activity and electron coupling capacity
The activity of individual mitochondrial electron transport
chain Complexes was determined immediately after isolation of
mitochondrial fraction [16,66] from RVLM. Enzyme activity
assay kits (MitoSciences, Eugene, OR, USA) for Complex I, II or
IV, and ATP synthase enzyme activity microplate assay kit
(MitoSciences) for Complex V were used in conjunction with a
spectrophotometer (Thermo Fisher Scientific Inc.); the activity of
Complex III was determined as described by Nadanaciva [67].
The activities of NCCR (marker enzyme for electron transport
capacity between Complexes I and III) or SCCR (marker enzyme
for electron transport capacity between Complexes II and III)
were analyzed as reported previously [14]. Total protein in the
Figure 10. Proposed mechanisms in RVLM that underlies METH-induced cardiovascular collapse. Intravenous administration of METH
rapidly reaches RVLM to induce anoxia and cessation of tissue perfusion, followed by bioenergetics failure and oxidative stress because of
mitochondrial dysfunction that lead to necrotic cell death. The loss of functionality in RVLM results in cessation of central cardiovascular regulation
and the eventual cardiovascular collapse.
doi:10.1371/journal.pone.0030589.g010
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(Pierce, Rockford, IL, USA).
Measurement of mitochondrial superoxide anion
Mitochondria-derived superoxide anion in RVLM was deter-
mined quantitatively by an ELISA method based on MitoSOX
(Molecular Probes) [64] in conjunction with spectrofluorometer
(Gemini EM Microplate Spectrofluorometer, Sunnyvale, CA,
USA), or semi-quantitatively by the intensity of fluorescence
determined by an analysis program (Fluoview FV10-ASW
Version.02.01) in conjunction with laser scanning confocal
microscopy (Olympus).
Statistical Analysis
All values were expressed as mean 6 SEM. The temporal
effects of various treatments on MAP, HR or power density of the
LF component were assessed using two-way analysis of variance
(ANOVA) with repeated measures for group means. Individual
biochemical parameters were assessed with one-way ANOVA. In
both cases, Scheffe ´ multiple-range test was used for post hoc
comparison of individual means. Mortality was assessed with the
Fisher Exact Test. P,0.05 was considered to be statistically
significant.
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